Immunovia strengthens US organization to continue commercialization of its novel IMMray™ PanCan-d test ...Middle East

LUND, Sweden, Dec. 5, 2022 /PRNewswire/ -- Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company that has launched the world's first blood test dedicated to the early detection of pancreatic cancer, today announced that its U.S. subsidiary, Immunovia Inc., has appointed a new...

Hence then, the article about immunovia strengthens us organization to continue commercialization of its novel immray pancan d test was published today ( Monday 05/12/2022 - 11:13 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Immunovia strengthens US organization to continue commercialization of its novel IMMray™ PanCan-d test )

Also on site :

• Another Weight Loss Surgery and a Wedding Bombshell: Spoilers From '1000-Lb Sisters' Season 8 Episode 2
• Trump-Iran latest: President threatens ‘very strong action’ if protesters are hanged after forced confessions
• High Potential Finally Explores Morgan And Ludo's Breakup, But EP Says There's More To The Story: 'It's Complicated'